Corbus Pharmaceuticals presented new data from the first Western study of its antibody-drug conjugate treatment for cancer.

Cancer breakthrough as scientists find way to spot aggressive tumours before they spread - The discovery could pave the way ...

The American Cancer Society estimates that 67,400 Americans will be diagnosed with pancreatic cancer this year and nearly ...

More than 74,000 cancer patients in England did not start treatment on time last year, according to new analysis. It comes as ...

Research at City of Hope reveals how common white button mushrooms might enhance prostate cancer treatment through surprising ...

Eli Lilly & Co. tapped the US investment-grade bond market on Monday to help finance its roughly $2.5 billion purchase of a ...

The 63-year-old musician revealed his stage 4 prostate cancer diagnosis in November 2022, saying his cancer was “asymptomatic” after he was initially diagnosed in 2018.

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

It is a useful therapy with several drawbacks that limit its effectiveness, including prolonged light sensitivity, poor tissue penetration and off-target toxicity. These drawbacks can prevent complete ...

Combining talazoparib with enzalutamide significantly improves overall survival in patients with metastatic ...

When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the skin may be just as effective as traditional means of administration with ...

A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes -- insights that could help doctors tailor treatments more effectively. The largest study of its ...